The board of directors of Sino Biopharmaceutical Limited announced that Mr. Wang Shanchun ("Mr. Wang") has resigned as an executive director of the Company, as he wishes to pursue other business development, with effect from 2 November 2022. Mr. Wang confirmed that he has no disagreement with the Board and that there are no matters which need to be brought to the attention of the shareholders of the Company or the Stock Exchange of Hong Kong Limited in relation to his resignation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.13 HKD | +1.29% | +2.29% | -9.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.80% | 7.26B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.66% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 1177 Stock
- News Sino Biopharmaceutical Limited
- Sino Biopharmaceutical Limited Announces Resignation of Wang Shanchun as Executive Director